Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation.
David RombautCarine LefèvreTony RachedSabrina BonduAnne LetessierRaphaël M MangioneBatoul FarhatAuriane Lesieur-PasquierDaisy Castillo-GuzmanIsmael BoussaidChloé FriedrichAurore TourvilleMagali De CarvalhoFrancoise LevavasseurMarjorie LeducMorgane Le-GallSarah BattaultMarie TempleAlexandre HouyDidier BouscaryLise WillemsSophie ParkSophie RaynaudThomas CluzeauEmmanuelle ClappierPierre FenauxLionel AdesRaphaël MargueronMichel WassefSamar AlsafadiNicolas ChapuisOlivier KosmiderEric SolaryAngelos ConstantinouMarc-Henri SternNathalie M DroinBenoit PalancadeBenoit MiottoFrédéric ChedinMichaela FontenayPublished in: Nature communications (2024)
Myelodysplastic syndromes (MDS) with mutated SF3B1 gene present features including a favourable outcome distinct from MDS with mutations in other splicing factor genes SRSF2 or U2AF1. Molecular bases of these divergences are poorly understood. Here we find that SF3B1-mutated MDS show reduced R-loop formation predominating in gene bodies associated with intron retention reduction, not found in U2AF1- or SRSF2-mutated MDS. Compared to erythroblasts from SRSF2- or U2AF1-mutated patients, SF3B1-mutated erythroblasts exhibit augmented DNA synthesis, accelerated replication forks, and single-stranded DNA exposure upon differentiation. Importantly, histone deacetylase inhibition using vorinostat restores R-loop formation, slows down DNA replication forks and improves SF3B1-mutated erythroblast differentiation. In conclusion, loss of R-loops with associated DNA replication stress represents a hallmark of SF3B1-mutated MDS ineffective erythropoiesis, which could be used as a therapeutic target.